Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00654693 · ClinicalTrials.gov registry record
NTX Wireless Patient Monitoring System
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 26
- Enrollment target
NCT00654693: Completed study, sponsored by Vanderbilt University.
NCT00654693 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00654693 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
* Determine the accuracy of the NTX wireless monitoring system alerts * Evaluate patient compliance with wearing device * Determine false alarm rates
Interventions
- OTHER Rapid Response Team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-06 |
What the finished NCT00654693 record still lists
NCT00654693 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Rapid Response Team is the first listed.
NCT00654693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00654693 about?
NCT00654693 is a clinical study titled "NTX Wireless Patient Monitoring System". * Determine the accuracy of the NTX wireless monitoring system alerts * Evaluate patient compliance with wearing device * Determine false alarm rates
What is the current status of trial NCT00654693?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00654693?
The interventions under investigation include: Rapid Response Team (OTHER).
Who is sponsoring clinical trial NCT00654693?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia